Running Oak Capital’s ResMed RMD Stock Holding History

Running Oak Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.05M	Sell	41,308 -16,489	-29%	-$3.42M	1.37%	52
2026 Q1	$13M	Sell	57,797 -3,028	-5%	-$755K	1.75%	37
2025 Q4	$14.7M	Sell	60,825 -2,683	-4%	-$686K	1.84%	29
2025 Q3	$17.4M	Sell	63,508 -2,453	-4%	-$670K	1.95%	14
2025 Q2	$17M	Sell	65,961 -1,883	-3%	-$449K	1.89%	16
2025 Q1	$15.2M	Buy	+67,844	New	+$15.8M	1.83%	33

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Running Oak Capital's RMD Position: Q2 2026 in Review

Running Oak Capital reduced its ResMed (RMD) stake by 29% in Q2 2026, selling an estimated $3.42M and leaving 41,308 shares worth $8.05M. The position accounts for 1.37% of the portfolio, ranked #52.

Running Oak Capital first reported a position in RMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $17.4M in Q3 2025. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Running Oak Capital held 41,308 shares of ResMed worth $8.05M as of Q2 2026.
Running Oak Capital sold 16,489 ResMed shares in Q2 2026, an estimated $3.42M.
ResMed made up 1.37% of Running Oak Capital's portfolio in Q2 2026, its #52 holding.
Running Oak Capital first reported a position in ResMed in Q1 2025 and has held it in 6 quarters since.
Running Oak Capital's ResMed position peaked at $17.4M in Q3 2025.
889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Running Oak Capital's 13F filing for Q2 2026, filed 30 Jul 2026.